Carreras-Torras C, Gay-Escoda C. Techniques for early diagnosis of oral squamous cell carcinoma: Systematic review. Med Oral Patol Oral Cir Bucal. 2015 May 1;20 (3):e305-15. 

 

 

doi:10.4317/medoral.20347

http://dx.doi.org/doi:10.4317/medoral.20347

 

 

1. Jayanthi JL, Mallia RJ, Shiny ST, Baiju KV, Mathews A, Kumar R, et al. Discriminant analysis of autofluorescence spectra for classification of oral lesions in vivo. Lasers Surg Med. 2009;41:345-52.
http://dx.doi.org/10.1002/lsm.20771

 

2. Mishra R. Biomarkers of oral premalignant epithelial lesions for clinical application. Oral Oncol. 2012;48:578-84.
http://dx.doi.org/10.1016/j.oraloncology.2012.01.017

 

3. Marocchio LS, Lima J, Sperandio FF, Corra L, de Sousa SO. Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. J Oral Sci. 2010;52:267-73.
http://dx.doi.org/10.2334/josnusd.52.267

 

4. Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM. Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev. 2012;21:460-6.
http://dx.doi.org/10.1097/CEJ.0b013e32834fdb6d

 

5. Koch FP, Kunkel M, Biesterfeld S, Wagner W. Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity: A prospective and blinded study. Clin Oral Investig. 2011;15:763-9.
http://dx.doi.org/10.1007/s00784-010-0434-6

 

6. Remmerbach TW, Meyer-Ebrecht D, Aach T, WŸrflinger T, Bell AA, Schneider TE, et al. Toward a multimodal cell analysis of brush biopsies for the early detection of oral cancer. Cancer. 2009;117:228-35.
http://dx.doi.org/10.1002/cncy.20028

 

7. Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010;141:509-20.
http://dx.doi.org/10.14219/jada.archive.2010.0223

 

8. Messadi DV. Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci. 2013;5:59-65.
http://dx.doi.org/10.1038/ijos.2013.24

 

9. Sloan P. Squamous cell carcinoma and precursor lesions: clinical presentation. Periodontol 2000. 2011;57:10-8.
http://dx.doi.org/10.1111/j.1600-0757.2011.00391.x

 

10. Bhalang K, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L, Swasdison S. The application of acetic acid in the detection of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:371-6.
http://dx.doi.org/10.1016/j.tripleo.2008.01.017

 

11. Bhatia N, Lalla Y, Vu AN, Farah CS. Advances in optical adjunctive AIDS for visualisation and detection of oral malignant and potentially malignant lesions. Int J Dent. 2013;2013:194029.
http://dx.doi.org/10.1155/2013/194029

 

12. Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J. 2012;6:126-30.
http://dx.doi.org/10.2174/1874210601206010126

 

13. Chen YW, Lin JS, Wu CH, Lui MT, Kao SY, Fong Y. Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral squamous cell carcinoma and precancer lesions. J Chin Med Assoc. 2007;70:497-503.
http://dx.doi.org/10.1016/S1726-4901(08)70048-0

 

14. Saini R, Poh CF. Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders. Oral Dis. 2013;19:440-51.

 

15. Epstein JB, GŸneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg. 2009;17:79-87.
http://dx.doi.org/10.1097/MOO.0b013e32832771da

 

16. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-80.
http://dx.doi.org/10.1111/j.1600-0714.2007.00582.x

 

17. Feller L, Lemmer J. Oral Leukoplakia as It Relates to HPV Infection: A Review. Int J Dent. 2012;2012:540561.
http://dx.doi.org/10.1155/2012/540561

 

18. Sciubba JJ. Oral Cancer: The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001;4:239-51.
http://dx.doi.org/10.2165/00128071-200102040-00005

 

19. Dos santos Pereira J, De Vasconcelos Carvalho M, Gomes Henriques AC, De Queiroz Camara TH, De Costa Miguel MC, De Almeida Freitas R. Epidemiology and correlation of the clinicopathlogical features in oral epitelial displasia: Analysis of 173 cases. Ann Diagn Pathol. 2011;15:98-102.
http://dx.doi.org/10.1016/j.anndiagpath.2010.08.008

 

20. Hanken H, Kraatz J, Smeets R, Heiland M, Assaf AT, Blessmann M, et al. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscopeª) - a single blinded clinical evaluation. Head Face Med. 2013;9:23.
http://dx.doi.org/10.1186/1746-160X-9-23

 

21. Moro A, Di Nardo F, Boniello R, Marianetti TM, Cervelli D, Gaspardini G, et al. Autofluorescence and early detection of mucosal lesions in patients at risk for oral cancer. J Craniofac Surg. 2010;21:1899-903.
http://dx.doi.org/10.1097/SCS.0b013e3181f4afb4

 

22.Pentenero M, Navone R, Motta F, Marino R, Gassino L, Broccoletti R, et al. Clinical features of microinvasive stage I oral carcinoma. Oral Dis. 2011;17:298-303.
http://dx.doi.org/10.1111/j.1601-0825.2010.01740.x

 

23. Mehrotra R, Yadav S. Oral squamous cell carcinoma: Etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer. 2006;43:60-6.
http://dx.doi.org/10.4103/0019-509X.25886

 

24. Lingen MW, Pinto A, Mendes RA, Franchini R, Czerninski R, Tilakaratne WM, et al. Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis. 2011;17:7-22.
http://dx.doi.org/10.1111/j.1601-0825.2011.01789.x

 

25. Bremmer JF, Graveland AP, Brink A, Braakhuis BJ, Kuik DJ, Leemans CR, et al. Screening for oral precancer with noninvasive genetic cytology. Cancer Prev Res (Phila). 2009;2:128-33.
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0128

 

26. Brocklehurst PR, Baker SR, Speight PM. A qualitative study examining the experience of primary care dentists in the detection and management of potentially malignant lesions. 1. Factors influencing detection and the decision to refer. Br Dent J. 2010;208:72-3.
http://dx.doi.org/10.1038/sj.bdj.2010.99

 

27. Garg P, Karjodkar F. "Catch Them before it Becomes Too Late"-Oral Cancer Detection. Report of Two Cases and Review of Diagnostic AIDS in Cancer Detection. Int J Prev Med. 2012;3:737-41.

 

28. Epstein JB, Silverman S, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008;44:538-44.
http://dx.doi.org/10.1016/j.oraloncology.2007.08.011

 

29. Epstein JB, Guneri P, Boyacioglu H, Abt E. The limitations of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma. J Am Dent Assoc. 2012;143:1332-42.
http://dx.doi.org/10.14219/jada.archive.2012.0096

 

30. Bremmer JF, Braakhuis BJ, Ruijter-Schippers HJ, Brink A, Duarte HM, Kuik DJ, et al. A noninvasive genetic screening test to detect oral preneoplastic lesions. Lab Invest. 2005;85:1481-8.
http://dx.doi.org/10.1038/labinvest.3700342

 

31. Delavarian Z, Mohtasham N, Mosannen-Mozafari P, Pakfetrat A, Shakeri MT, Ghafoorian-Maddah R. Evaluation of the diagnostic value of a Modified Liquid-Based Cytology using OralCDx Brush in early detection of oral potentially malignant lesions and oral cancer. Med Oral Patol Oral Cir Bucal. 2010;15:e671-6.
http://dx.doi.org/10.4317/medoral.15.e671

 

32. Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003;106:404-8.
http://dx.doi.org/10.1002/ijc.11245

 

33. Epstein JB, Scully C, Spinelli J. Toluidine blue and lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med. 1992;21:160-3.
http://dx.doi.org/10.1111/j.1600-0714.1992.tb00094.x

 

34. Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol. 1989;67:621-7.
http://dx.doi.org/10.1016/0030-4220(89)90286-7

 

35. Peng G, Long Q, Wu Y, Zhao J, Chen L, Li X. Evaluation of double vital staining with lugol's iodine and methylene blue in diagnosis superficial esophageal lesions. Scand J Gastroenterol. 2011;46:406-13.
http://dx.doi.org/10.3109/00365521.2010.545829

 

36. Du GF, Li CZ, Chen HZ, Chen XM, Xiao Q, Cao ZG, et al. Rose bengal staining in detection of oral precancerous and malignant lesions with colorimetric evaluation: a pilot study. Int J Cancer. 2007;120:1958-63.
http://dx.doi.org/10.1002/ijc.22467

 

37. Watanabe A, Taniguchi M, Tsujie H, Hosokawa M, Fujita M, Sasaki S. Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin. Auris Nasus Larynx. 2012;39:193-7.
http://dx.doi.org/10.1016/j.anl.2011.08.004

 

38. Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literatura. J Am Dent Assoc. 2008;139:896-905.
http://dx.doi.org/10.14219/jada.archive.2008.0276

 

39. Lingen MW, Kalmar JR, Karrison T, Speigh PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10-22.
http://dx.doi.org/10.1016/j.oraloncology.2007.06.011

 

40. Koch FP, Kaemmerer PW, Biesterfeld S, Kunkel M, Wagner W. Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial. Clin Oral Investig. 2011;15:975-82.
http://dx.doi.org/10.1007/s00784-010-0455-1

 

41. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006;11:024006.
http://dx.doi.org/10.1117/1.2193157

 

42. McNamara K, Martin BD, Evans EW, Kalmar JR. The role of direct visual fluorescent examination (VELscope) in routine screening for potentially malignant oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:636-43.
http://dx.doi.org/10.1016/j.oooo.2012.07.484

 

43. Schwarz RA, Gao W, Redden Weber C, Kurachi C, Lee JJ, El-Naggar AK, et al. Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy: Simple device for the direct visualization of oral-cavity tissue fluorescence. Cancer. 2009;115:1669-79.
http://dx.doi.org/10.1002/cncr.24177

 

44. McGee S, Mirkovic J, Mardirossian V, Elackattu A, Yu CC, Kabani S, et al. Model-based spectroscopic analysis of the oral-cavity: Impact of anatomy. J Biomed Opt. 2008;13:064034.
http://dx.doi.org/10.1117/1.2992139

 

45. Roblyer D, Furachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, et al. Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res(Phila). 2009;2:423-31.
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0229

 

46. Nguyen P, Bashirzadeh F, Hodge R, Agnew J, Farah CS, Duhig E, et al. High specificity of combined narrow band imaging and autofluorescence mucosal assessment of patients with head and neck c‡ncer. Head Neck. 2013;35:619-25.
http://dx.doi.org/10.1002/hed.22999

 

47. Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A, Sadecki D. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions. J Craniofac Surg. 2012;23:162-4.
http://dx.doi.org/10.1097/SCS.0b013e31824cdbea

 

48. Goodson ML, Thomson PJ. Management of oral carcinoma: Benefits of early precancerous intervention. Br J Oral Maxillofac Surg. 2011;49:88-91.
http://dx.doi.org/10.1016/j.bjoms.2009.12.014

 

49. Cercadillo-Ibarguren I, Espa-a-Tost A, Arnabat-Dom’nguez J, Valmaseda-Castell—n E, Berini-AytŽs L, Gay-Escoda C. Histologic evaluation of thermal damage produced on soft tissues by CO2, Er,Cr:YSGG and diode lasers. Med Oral Patol Oral Cir Bucal. 2010;15:e912-8.
http://dx.doi.org/10.4317/medoral.15.e912

 

50. Fontes KB, Cunha KS, Rodriguez FR, Silva LE, DIas EP. Concordance between cytopathology and incisional biopsy in the diagnosis of oral squamous cell carcinoma. Braz Oral Res. 2013;27:122-7.

 

51. KŠmmerer PW, Koch FP, Santoro M, Babaryka G, Biesterfeld S, Brieger J, et al. Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy. Oral Oncol. 2013;49:420-6.
http://dx.doi.org/10.1016/j.oraloncology.2012.12.006

 

52. Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer. 2006;5:11.
http://dx.doi.org/10.1186/1476-4598-5-11

 

53. …gmundsd—ttir HM, Hilmarsd—ttir H, Bjšrnsson J, Holbrook WP. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders. J Oral Pathol Med. 2009;38:716-21.
http://dx.doi.org/10.1111/j.1600-0714.2009.00767.x

 

54. Donadini A, Maffei M, Cavallero A, Pentenero M, Malacarne D, Di Nallo E, et al. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry. Cell Oncol. 2010;32:373-83.

 

55. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001;61:939-42.

 

56. Huang MF, Chang YC, Liao PS, Huang TH, Tsay CH, Chou MY. Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology. Oral Oncol. 1999;35:296-301.
http://dx.doi.org/10.1016/S1368-8375(98)00119-5

 

57. Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol. 2000;36:525-8.
http://dx.doi.org/10.1016/S1368-8375(00)00045-2

 

58. Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A'Hern RP, Langdon JD. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field cancerization. Cancer Res. 2000;60:3893-8.

 

59. Remmerbach TW, Weidenbach H, Muller C, Hemprich A, Pomjanski N, Buckstegge B, et al. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol. 2003;25:139-46.
http://dx.doi.org/10.1155/2003/647685

 

60. Nayak S, Goel MM, Chandra S, Bhatia V, Mehrotra D, Kumar S, et al. VEGF-A immunohistochemical and mRNA expression in tissues and its serum levels in potentially malignant oral lesions and oral squamous cell carcinomas. Oral Oncol. 2012;48:233-9.
http://dx.doi.org/10.1016/j.oraloncology.2011.10.003

 

61. Scott IS, Odell E, Chatrath P, Morris LS, Davies RJ, Vowler SL, et al. A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia. Br J Cancer. 2006;94:1170-5.
http://dx.doi.org/10.1038/sj.bjc.6603066

 

62. Liao CT, Fan KH, Lin CY, Wang HM, Huang SF, Chen IH, et al. Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread. Eur J Nucl Med Mol Imaging. 2012;39:944-55.
http://dx.doi.org/10.1007/s00259-012-2103-2

 

63. Hamdoon Z, Jerjes W, Upile T, McKenzie G, Jay A, Hopper C. Optical coherence tomography in the assessment of suspicious oral lesions: An immediate ex vivo study. Photodiagnosis Photodyn Ther. 2013;10:17-27.
http://dx.doi.org/10.1016/j.pdpdt.2012.07.005

 

64. Jerjes W, Upile T, Conn B, Hamdoon Z, Betz CS, McKenzie G, et al. In vitro examination of suspicious oral lesions using optical coherence tomography. Br J Oral Maxillofac Surg. 2010;48:18-25.
http://dx.doi.org/10.1016/j.bjoms.2009.04.019

 

65. Ahn YC, Chung J, Wilder-Smith P, Chen Z. Multimodality approach to optical early detection and mapping of oral neoplasia. J Biomed Opt. 2011;16:076007.
http://dx.doi.org/10.1117/1.3595850